Extended Follow-up of Autologous Bone Marrow Transplantation with 4-Hydroperoxycyclophosphamide (4-HC) Purging for Indolent or Transformed Non-Hodgkin Lymphomas

This publication has 37 references indexed in Scilit:

• Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma
  Annals of Oncology, 2010
• Cyclophosphamide and cancer: golden anniversary
  Nature Reviews Clinical Oncology, 2009
• Circulating clonotypic B cells in classic Hodgkin lymphoma
  Blood, 2009
• Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
  Blood, 2008
• Long-Term Outcomes of Autologous Stem Cell Transplantation for Follicular Non-Hodgkin Lymphoma: Effect of Histological Grade and Follicular International Prognostic Index
  Transplantation and Cellular Therapy, 2008
• Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance
  Cancer Research, 2008
• Syngeneic Hematopoietic Stem-Cell Transplantation for Non-Hodgkin’s Lymphoma: A Comparison With Allogeneic and Autologous Transplantation—The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
  Journal of Clinical Oncology, 2003
• A Proportional Hazards Model for the Subdistribution of a Competing Risk
  Journal of the American Statistical Association, 1999
• Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide
  New England Journal of Medicine, 1986
• Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide
  New England Journal of Medicine, 1983